Lifecore Biomedical, Inc.
LFCRLifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development and aseptic filling of complex, highly viscous sterile injectable pharmaceuticals and medical devices.
Earnings
Next report
Date not yet announcedFinancials
Q1 2027Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development and aseptic filling of complex, highly viscous sterile injectable pharmaceuticals and medical devices. The company is a leading manufacturer of non-animal-sourced hyaluronic acid (HA) and provides end-to-end services from analytical development to commercial-scale manufacturing. Their value proposition centers on proprietary fermentation processes and specialized capabilities in handling difficult-to-fill formulations for global biopharmaceutical partners.
A leading U.S. manufacturer of non-animal-sourced HA with specialized expertise in high-viscosity aseptic filling that serves as a high-barrier-to-entry niche.
FAQ
- What is Lifecore Biomedical, Inc.'s market cap?
- Lifecore Biomedical, Inc. (LFCR) has a market capitalization of $242.6M and trades on NASDAQ.
- Who are Lifecore Biomedical, Inc.'s competitors?
- Lifecore Biomedical, Inc.'s key competitors include Baxter International, Thermo Fisher Scientific, ADMA Biologics, Inc., and others. These companies compete in similar markets and product categories.
- Who does Lifecore Biomedical, Inc. partner with?
- Lifecore Biomedical, Inc.'s notable partners include BMO Harris Bank N.A., 22NW, LP.
- Where is Lifecore Biomedical, Inc. headquartered?
- Lifecore Biomedical, Inc. is headquartered in United States of America and employs approximately 459 people. It has been publicly traded since 1996.